Mondias specializes in the commercialization and development of evidence based botanical products for the health care and bio agriculture markets. The company is already selling both oral and topical botanical agents to help manage unmet medical needs through Holizen Laboratories, one of its divisions. Mondias is also developing botanical-based specialty fertilizers for use on household plants, urban gardens, lawns, golf courses, nurseries or greenhouses in collaboration with McGill's faculty of agricultural and environmental sciences.

1. Investors Presentation
December 2018
TSXV | NHP
PRIVATE & CONFIDENTIAL
The information contained herein is not intended to be a source of
investment advice on Mondias Natural Products or the material presented.

2. Forward Looking Statement
This presentation contains forward-looking statements that reflect the Company’s
current expectation regarding future events. There is a risk that expectations and
forward looking statements will not prove to be accurate.
Readers are cautioned not to place undue reliance on these forward looking
statements as they involve risks and uncertainties, which could make actual
results differ materially from those projected herein and depend on a number of
factors including, but not limited to, no history of profitability, future financing,
intellectual property and patents, key personnel, competitive marketplace,
technology obsolescence, share price volatility and other risks detailed from time
to time in the Company’s filings.
While Mondias anticipates that subsequent events and developments may cause
its views to change, Mondias specifically disclaims any obligation to update these
forward looking statements, unless obligated to do so by applicable securities
laws.

3. Our Mission
"Develop and provide natural solutions with efficacy
evidence to fulfill unmet needs in human health and
agricultural markets"

4. Holizen business expanding nationally in 2019 in natural health
products stores and pharmacies.
• Robust pipeline of 8 natural health products to launched in 2019 and sell
through co-branding partnerships and multi-channel approach.
• Targeting of high potential and high growth markets in sleep, pain,
acne, onychomycosis and hair loss.
• Ongoing research, development and field testing on high revenue
potential bio pesticide + bio stimulant products for agricultural market.
• Experienced management team and expertise in natural products
development and commercialization.
• Strong portfolio of IP : 53 NPN and 4 patents.
Executive Summary

5. Management Team
Jean-Philippe Gravel
BBA, MBA
CEO
• JP has over 14 years of experience in
business management and development,
having worked in key strategic roles for
the medical, pharmaceutical and banking
industries. He specializes in sales and
marketing strategies as well as business
consolidation.
• He previously served as CEO of Triple Hair
Inc, a biotech company specializing in the
development of hair loss solutions.
Sabino Di Paola
CA, CPA
CFO
• Sabino has over a decade of experience in
audit, finance and accounting as an
auditor for PricewaterhouseCoopers and
BDO Canada and has been involved with
numerous financing and spin out
transactions
• He is currently CFO for Cornerstone
Capital Resources, Everton resources and
Melkior Resources
TBC – January 2019 (target)
CSO
• PHD in Plant Science

6. Board of Directors
André Rancourt
Chairman
• André is the co-founder
of Mondias Naturals.
• He is highly experienced
in management, start-
ups, and commercial
strategies. He previously
held the roles of CEO
and Chairman for Tetra
Biopharma. He also
worked as a consultant
on behalf of several
venture capital
investment funds.
Michel Timperio
Director
• Michel is President -
Cannabis Business at
Neptune Technologies &
Bioresources, Inc.
• He also currently sits on
the Board of Directors at
Relevium Technologies,
Inc. a company
specializing in natural
products online sells and
Relief Ventures a private
company which is
building an online
market place for Hemp
derived molecules.
Frank Palantoni
Director
• Frank is the current CEO
of LabM2 a company
developing sustainable
disinfecting
technologies.
• He previously served as
president of Pet and Life
Science, Global CEO of
Gerber Products, CEO of
Novartis Consumer
Health and was amongst
the top executives at
Groupe Danone, and
Procter & Gamble.
Bertrand Venne
Director
• Bertrand currently
works as a consultant
and business
administrator for
various firms. He
served as a mentored
for numerous start-ups
• He previously was
President and CEO of
Entreprise pâtes et
croûtes and Aliments
Novali.
Louis Doyle
Director
• Louis has over 30 years
of experience in capital
markets and stock
exchange listings. He
currently is the
Executive Director of
Quebec Bourse.
• He previously worked for
15 years as Vice-
President for TSX-V
Montreal where he was
Chair of the Executive
Listing Committee and a
member of the Policy
Committee.

7. Development and
commercialization of
effective natural health
products (OTC)
Development and
commercialization of
efficacy evidence based
biopharmaceutical
products
Development and
commercialization of
efficacy evidence based
agricultural products
Consumer Health Natural Pharmaceutical Crop Science and
Innovation

8. Strategic Goals
MONDIAS goal is to reach over 40 M$ in sales and over 30% of
net margin within 5 years through company & product
acquisitions in addition to the development & commercialization
of MONDIAS formulations.
MONDIAS will use a virtual structure with key partnerships to
achieve company sales milestones before developing new
markets, investing in R&D and having its own production facilities.

9. Growth Strategy
IP Valuation
• International patents
• Robust legal protection
• Strong clinical trials
Acquisitions
• Company with strong profit track record
• Company with complementary
technology / products and established
distribution channels
• Start-ups with unique niche products
Multi-Channel Sales
• Retail (Pharmacies and NHP stores)
• Web Sales
• MLM
• Co-Branding and licensing
Product Launch
• Consumer Health
• Pharmaceutical
• Crop Science and Innovation

10. Consumer Health
Anticipated Product Launch Date Calendar*
Q1 2019 Q2 2019 Q3 2019 Q4 2019 Q1 2020
Q2-Q4
2020
Hair
Regrowth
Men (OTC)
Acne
Sleep
Anxiety
Insect
Repellent
Nail
Fungus
Athlete’s
Foot
Hair
Regrowth
Women
Pain
Relief
Hair
Regrowth
Men
(DIN-OTC)
*Dates subject to change

11. Pharmaceutical
Product Pipeline
Sleep (CALPXT96)
Nail Fungus
Dr. Lee
DISCOVERY
PRE-
CLINICAL
CTA/IND PHASE 1 PHASE 2 PHASE 3 PHASE 4

12. Crop Science and Innovation
Anticipated Product Launch Date Calendar*
Field Test
Field Test
Viticulture
Commercialisation (phase 1)
Canada
Commercialisation (phase 2)
USA
Canabis
Production
Viticulture
Agriculture and
Horticulture
Consumer
Co-Development
Soft Launch
(Phase 1)
South
America
Full Launch
(Phase 1)
Co-Development
Soft Launch
(Phase 1)
Market Type Q4 2018
Q1-Q2
2019
Q3-Q4
2019
Q1-Q2
2020
Q3-Q4
2020
2021
Soft Launch
(Phase 1)
Full Launch
(Phase 1)
*Dates subject to change

13. Market Opportunities
Sleep Aid Global sleep aids market was valued at $US 49.5 B in 2016 and is
estimated to reach $79.8 billion by 2022
Acne Global market was valued at $US 4.92B in 2016 and projected to reach a
value of US$ 7.35B in 2026
Nail Fungus Global market estimated to account for US$ 3.1B in 2015 and reach a
value of US$ 6.7B by the end of 2026
Wound Healing Global market was valued at $US 23.3B in 2016 and projected to reach a
value of US$ 35B in 2026
Hair Regrowth Global hair loss market was valued at $US 7.3B in 2015 and is expected to
reach $US 11.4B in 2024
Insect Repellent Global insect repellent is expected to grow at a rate of CAGR of 6.5% from
2018 to 2026 to reach US$ 7B
Bio Pesticide Global Market is valued at $US 3.22B and projected to grow to $US 6,60B
by 2022
Bio Stimulants Biostimulant market is valued at $US 2B and projected to grow to $US
3.29B by 2022

14. Capitalization
Mondias Natural Products Inc. TSXV : NHP
Price per share 0,20$
Number of shares 63,135,805
Warrants 6,882,760 @ 0,25$
Options 400,402
Number of shares fully diluted 70,418,966
Market cap ($M) $12,6M
Insider ownership 36,333,334

15. Contact Information
Jean-Philippe Gravel - CEO
jpgravel@mondias.ca
1 866-722-2442